Jon Napitupulu

Sai Life Sciences has published its 2024–25 sustainability report, aligning with GRI Universal Standards 2021 and SASB, and outlining...

BioSyent has received TSX Venture Exchange approval to launch a normal course issuer bid allowing the company to repurchase...

Organogenesis has secured FDA alignment to begin a rolling Biologics License Application for Renu, a cryopreserved amniotic suspension allograft...

Singlera Genomics and Breakthrough Genomics have initiated a research collaboration with the University of Pittsburgh to advance preclinical evaluation...

PeptiNovo Biopharma has secured a manufacturing and IP milestone that could unlock clinical entry for its targeted chemotherapy platform,...

Dyadic Applied Biosolutions has expanded its collaboration with Fermbox Bio, granting Fermbox rights to manufacture and commercialize multiple Dyadic-origin...

Rakovina Therapeutics will use JPM Week 2026 to court partners and investors on the back of new preclinical data...

Inventiva reported €97.6 million in cash and cash equivalents as of September 30, 2025, €4.5 million in revenue for...

Nanobiotix has closed a non-dilutive royalty financing with Healthcare Royalty for up to $71 million, securing $50 million upfront...

Cellectar Biosciences has signed a multi-year supply agreement with IONETIX for cGMP-grade actinium-225 and astatine-211 to support clinical development...